drugset
drugset / Trial / NCT00904605

Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee

NCT00904605 ↗

Phase 4 Terminated Endo USA Inc., a Keenova Therapeutics Company
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients with unilateral or bilateral osteoarthritis of the knee participated in a Phase IV clinical trial to assess the efficacy of Lidoderm compared with celecoxib 200mg in treating pain from osteoarthritis of the knee.

Timeline

Start
2004-06
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg Oral
Subject Lidocaine Other / unclassified 5 % Topical

Indications

osteoarthritis, knee